DEC 20, 2017 6:27 AM PST

A New Blood Biomarker for Alzheimer's?

While research is also ongoing into the causes of and treatments for Alzheimer's disease (AD), there is also a rush to find a way to predict whether or not someone will develop the neurodegenerative disease.

Being able to diagnose AD, as well as differentiate it from other forms of dementia, must be looked at alongside the search for medication to stall or reverse the disease and genetic or environmental factors that could be an underlying cause.

A team of neuroscientists at Seoul National University may have a lead in early detection of AD. Currently, a high-resolution positron emission tomography (PET) scan is the only way for medical professionals to see the beta-amyloid plaques in the brain that are most often associated with the disease. PET scans cannot always pick up every bit of tau proteins that are in the brain, however, and once they are visible on PET scans, the disease has usually progressed to moderate or severe levels, depending on the patient.

The team in Korea at Seoul National is partnering with pharmaceutical company Medifron DBT to market the test. While the presence of beta-amyloid plaques in the brain can be detected in the blood, they are proteins that are very often broken down in the bloodstream and do not reliably show up in the currently available biomarker assays. Levels of beta-amyloid are often compared to PET scan results to assess the accuracy, and the current biomarker testing isn't even close to 100% accurate.

The goal for the team was to come up with a way to process blood samples to halt the breakdown of the tau proteins was avoided. When they had developed what they thought was a process that could keep the AD proteins intact, they took blood samples from patients with the disease and compared them to PET scan studies. The rate of accuracy between the biomarker assay and the imaging was close to 90%. Also, their research showed the ability to find evidence of beta-amyloid levels in patients who had not even begun to show visible symptoms of the disease.

SNU professor Mook In-hee, who led the research, told the media in a Ministry of Science press release, "While most Alzheimer's diagnostics technologies identify the disease in patients with clearly visible symptoms, our technology can predict Alzheimer's even when a person is not showing symptoms. Our team also discovered beta-amyloids accumulating in the brains of patients who were not determined to have Alzheimer's according to cognitive tests."

The research was published in the journal Alzheimer's Research and Therapy. Medifron DBT has purchased the rights to license the technology and will work with the SNU team to start more extensive trials. There will also be a machine learning component to the research, with SNU computer scientists working on algorithms to improve accuracy.

The video below has more information on the recent research, check it out.

Sources: Inquirer.net, Business Korea, Alzheimer's Research and Therapy

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
AUG 25, 2020
Neuroscience
Fear of Germs Leading Factor in COVID-19 Preventative Behavior
AUG 25, 2020
Fear of Germs Leading Factor in COVID-19 Preventative Behavior
Researchers from the University of Connecticut have found that people with a psychological aversion to germs are more li ...
SEP 13, 2020
Neuroscience
Emotion-Color Associations are the Same Globally
SEP 13, 2020
Emotion-Color Associations are the Same Globally
Researchers from Johannes Gutenberg Universitaet Mainz in Germany have found that people, regardless of where they come ...
OCT 03, 2020
Neuroscience
Crows Have Conscious Thought, Just Like Primates
OCT 03, 2020
Crows Have Conscious Thought, Just Like Primates
Researchers from the University of Tubingen in Germany have found that crows are capable of conscious thought. They say ...
OCT 07, 2020
Neuroscience
Researchers Discover Molecular Mechanism for Memory Formation
OCT 07, 2020
Researchers Discover Molecular Mechanism for Memory Formation
Researchers from MIT have found that when the brain forms a new memory, neurons known as 'engram cells' encode t ...
OCT 22, 2020
Cannabis Sciences
Cannabis Reduces OCD Symptoms by 50%
OCT 22, 2020
Cannabis Reduces OCD Symptoms by 50%
Researchers from Washington State University have found that smoking cannabis can lead to a short term reduction in up t ...
NOV 01, 2020
Cannabis Sciences
Can Cannabis Treat ALS?
NOV 01, 2020
Can Cannabis Treat ALS?
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative illness that damages motor neurons and leads to progressive m ...
Loading Comments...